Chad Cowan, Clade Therapeutics CEO
CRISPR Therapeutics co-founder uncloaks an off-the-shelf cell therapy startup with $87M and a lot of fanfare
When Chad Cowan was recruited to Harvard University 20 years ago to work on human embryonic stem cells, he was inspired by the idea that …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
